Asthma is a chronic condition that affects millions of people around the world. It can range from mild to severe, and for those with severe asthma, the symptoms can be debilitating. Fortunately, there is a revolutionary new treatment option for those with severe asthma: Dupixent®. Dupixent® is a biologic medication that works by blocking two proteins that contribute to the inflammation and airway constriction associated with severe asthma. This innovative medication has the potential to significantly improve the quality of life for those living with severe asthma. In this article, we will discuss the benefits of Dupixent® and how it can help unlock a better quality of life for those with severe asthma.
Dupixent® is a biologic medication that works by blocking two proteins, interleukin (IL)-4 and IL-13, which are involved in the inflammation and airway constriction associated with severe asthma. It is administered through an injection every two weeks. Dupixent® is the only biologic medication approved by the FDA for the treatment of severe asthma in adults and adolescents 12 years and older.
Dupixent® has been shown to significantly reduce the symptoms of severe asthma and improve quality of life in those who take it. In clinical trials, patients taking Dupixent® showed a significant reduction in the number of times they experienced an asthma attack, as well as a decrease in their need for rescue inhalers. Patients also reported improved lung function and an increase in their overall quality of life.
Dupixent® is approved for the treatment of severe asthma in adults and adolescents 12 years and older. It is important to note, however, that Dupixent® is not recommended for those with mild to moderate asthma, as it is not effective in treating this form of the condition.
As with any medication, there are potential side effects associated with Dupixent®. The most common side effects include injection site reactions, upper respiratory infections, and headache. While these side effects are generally mild and can be managed with over-the-counter medications, it is important to discuss any potential side effects with your doctor before starting Dupixent®.
Dupixent® is a revolutionary new treatment option for those with severe asthma. It has been shown to significantly reduce the symptoms of severe asthma and improve quality of life in those who take it. While it is important to discuss any potential side effects with your doctor before starting Dupixent®, the potential benefits of this innovative medication can be life-changing for those living with severe asthma.
1.
The majority of cancer medications that receive expedited approval end up failing confirmatory trials.
2.
Eliminating the SRC-3 gene in immune cells causes an efficient, long-lasting anti-cancer response.
3.
novel technique for early myelodysplastic syndrome relapse detection in blood cancer patients.
4.
Certain Oral Bacteria May Be a Risk Factor for Head and Neck Cancer
5.
Antibody Drug-Conjugate Shows Promising Activity in Extensive-Stage SCLC
1.
Chemotherapy Advances: Albumin I.V., Trastuzumab, Liposomal Doxorubicin & More
2.
The Architect's Dilemma: Remodeling the Tumor Microenvironment for a New Era of Cancer Immunotherapy
3.
The Pivotal Role of Telomerase in Breast Cancer Therapy Resistance and Treatment Strategies
4.
Understanding Bone Metastases: How Long Can Someone Live When Cancer Spreads To The Bones?
5.
Unveiling the Invisible: The Transformative Role of Radiomics in Precision Oncology
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part IV
2.
ESMO Breast Cancer 2022: P Reality X- A Restrospective Analysis
3.
The Evolving Landscape of First-Line Treatment for Urothelial Carcinoma
4.
Iron Deficiency Anemia: Ferric Maltol As a New Treatment Option- Summarization of the New Perspective
5.
EGFR Mutation Positive Non-Small Cell Lung Cancer- Case Discussion & Conclusion
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation